Capsule Endoscopy Improves Crohn's Disease Diagnosis
HealthDay News - Improved sensitivity and diagnosis compared with enterography for patients without stenosis
HealthDay News - For patients without endoscopic or clinical suspicion of stenosis, capsule endoscopy (CE) demonstrates improved sensitivity for detection of Crohn's disease (CD) in the terminal ileum and superior diagnosis in the proximal small bowel, according to a study published in the February issue of Clinical Gastroenterology and Hepatology.
Michael Dam Jensen, M.D., from Lillebaelt Hospital Vejle in Denmark, and colleagues examined data from 93 patients with inflammatory bowel disease who were scheduled to undergo ileocolonoscopy, magnetic resonance enterography (MRE), and computed tomography enterography (CTE). If stenosis was excluded, patients also underwent CE. Physicians performing the procedures were unaware of patient histories or findings from other examinations.
The investigators identified 21 patients with CD in the terminal ileum. For diagnosis of CD in the terminal ileum, CE had sensitivity and specificity of 100 and 91 percent, MRE had 81 and 86 percent, and CTE had 76 and 85 percent, respectively. Proximal CD was detected in 18 patients using CE, compared with two patients using MRE and six patients using CTE. Small bowel stenosis was seen in five patients using CTE and one patient using MRE. Cross-sectional imaging indicated additional stenosis in two of the patients who underwent complete ileocolonoscopies.
"In patients with suspected or newly diagnosed CD without endoscopic or clinical suspicion of stenosis, CE could be the new gold standard and first-line modality for detection of small bowel CD beyond the reach of the colonoscope," the authors write.
Copyright © 2011 HealthDay. All rights reserved.
Photon-Counting Computed Tomography: Eleven Takeaways from a New Literature Review
May 27th 2025In a review of 155 studies, researchers examined the capabilities of photon-counting computed tomography (PCCT) for enhanced accuracy, tissue characterization, artifact reduction and reduced radiation dosing across thoracic, abdominal, and cardiothoracic imaging applications.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.
